Terminated

A Study of LY3127804 in Participants With COVID-19

I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897

This study is a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.
How long will I be in the trial?
The study may last up to 9 weeks and include daily visits up to day 28, and follow-up visits by phone.
Email
Terminated

A Study of LY3127804 in Participants With COVID-19

I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897

This study is a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.
How long will I be in the trial?
The study may last up to 9 weeks and include daily visits up to day 28, and follow-up visits by phone.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must be admitted to the hospital for less than 48 hours with respiratory involvement

Participants must have confirmed pneumonia

Participants must have presumed or confirmed COVID-19

Participants must NOT

Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation

Participants must not have any serious medical condition or medication that prevents participation

Participants must not be at the point of death

Participants must not have had recent major surgery

Participants must not have had recent blood clots or events like heart attack

Participants must not have congestive heart failure or irregular heartbeat

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3127804, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

210

Trial Dates

April 2020 - October 2020

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must be admitted to the hospital for less than 48 hours with respiratory involvement

Participants must have confirmed pneumonia

Participants must have presumed or confirmed COVID-19

Participants must NOT

Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation

Participants must not have any serious medical condition or medication that prevents participation

Participants must not be at the point of death

Participants must not have had recent major surgery

Participants must not have had recent blood clots or events like heart attack

Participants must not have congestive heart failure or irregular heartbeat

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3127804, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

210

Trial Dates

April 2020 - October 2020

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

COVID-19 (Coronavirus) Resources

COVID-19

Lilly's COVID-19 Clinical Trials are Underway

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.
COVID-19

Types of Clinical Research for COVID-19

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.
COVID-19 teams chat

COVID-19 Research

COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?